Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 10/20 | 0.52 |
| ▸ | ITGAV | P06756 | 8/20 | 0.52 |
| ▸ | ITGB1 | P05556 | 2/20 | 0.52 |
| ▸ | ITGA5 | P08648 | 2/20 | 0.52 |
| ▸ | ITGB5 | P18084 | 5/20 | 0.51 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.46 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.46 |
| ▸ | MC4R | P32245 | 7/20 | 0.45 |
| ▸ | MC5R | P33032 | 7/20 | 0.45 |
| ▸ | MC3R | P41968 | 7/20 | 0.45 |
| ▸ | MC1R | Q01726 | 7/20 | 0.45 |
| ▸ | CTSG | P08311 | 2/20 | 0.45 |
| ▸ | ITGA2B | P08514 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23999259 | 0.94 | ITGB3 (0.52) | ITGB3ITGAVITGB1ITGA5ITGB5 | |
| SCHEMBL7743670 | 0.91 | ITGB3 (0.56) | ITGB3ITGAVITGB1ITGA5ITGB5 | |
| SCHEMBL22970321 | 0.91 | ITGB3 (0.56) | ITGB3ITGAVITGB1ITGA5ITGB5 | |
| SCHEMBL19981446 | 0.91 | ITGB3 (0.56) | ITGB3ITGAVITGB1ITGA5ITGB5 | |
| SCHEMBL7744260 | 0.91 | ITGB3 (0.56) | ITGB3ITGAVITGB1ITGA5ITGB5 | |
| SCHEMBL22738697 | 0.88 | KEAP1 (0.51) | ITGB3ITGAVITGB1ITGA5ITGB5 | |
| SCHEMBL22872747 | 0.86 | ITGB3 (0.51) | ITGB3ITGAVITGB1ITGA5ITGB5 | |
| SCHEMBL7744274 | 0.85 | KEAP1 (0.52) | ITGB3ITGAVITGB1ITGA5ITGB5 | |
| SCHEMBL20754200 | 0.84 | ITGB3 (0.53) | ITGB3ITGAVITGB1ITGA5ITGB5 | |
| SCHEMBL24285403 | 0.84 | ITGB3 (0.53) | ITGB3ITGAVITGB1ITGA5ITGB5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020238800-A1 | TARGETED RADIOPHARMACEUTICALS FOR TUMORS, AND COMBINATION THERAPY OF TARGETED RADIOTHERAPY THEREOF AND IMMUNOTHERAPY UNDER GUIDANCE OF IMAGES | 北京大学 | 2020-12-03 | — | — | WO | disclosed |